Clinical Trial Update: The Efficacy and Safety of Alverine in the Treatment of Portal Hypertension in Patients With Liver Cirrhosis [Phase 2, Phase 3]

View source ↗

Summary

Alverine is being evaluated in Phase 2 and Phase 3 trials for portal hypertension in patients with liver cirrhosis, and the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Cirrhosis
• Portal Hypertension

Drugs mentioned

• Alverine (Alverine citrate)

Snippet

Sponsor: Shanghai Changzheng Hospital | Conditions: Hypertension, Portal | Phase 2, Phase 3 | Status: NOT_YET_RECRUITING